Department of Clinical Neurosciences, Division of Neurosurgery, 1403 29 St. NW, Calgary, Alberta, T2N 2T9, Canada.
Department of Clinical Neurosciences, Division of Neurosurgery, 1403 29 St. NW, Calgary, Alberta, T2N 2T9, Canada; University of Calgary Combine Spine Program, 1403 29 St. NW, Calgary, Alberta, T2N 2T9, Canada.
Artif Intell Med. 2020 Mar;103:101785. doi: 10.1016/j.artmed.2019.101785. Epub 2019 Dec 31.
Despite the expanding use of machine learning (ML) in fields such as finance and marketing, its application in the daily practice of clinical medicine is almost non-existent. In this systematic review, we describe the various areas within clinical medicine that have applied the use of ML to improve patient care.
A systematic review was performed in accordance with the PRISMA guidelines using Medline(R), EBM Reviews, Embase, Psych Info, and Cochrane Databases, focusing on human studies that used ML to directly address a clinical problem. Included studies were published from January 1, 2000 to May 1, 2018 and provided metrics on the performance of the utilized ML tool.
A total of 1909 unique publications were reviewed, with 378 retrospective articles and 8 prospective articles meeting inclusion criteria. Retrospective publications were found to be increasing in frequency, with 61 % of articles published within the last 4 years. Prospective articles comprised only 2 % of the articles meeting our inclusion criteria. These studies utilized a prospective cohort design with an average sample size of 531.
The majority of literature describing the use of ML in clinical medicine is retrospective in nature and often outlines proof-of-concept approaches to impact patient care. We postulate that identifying and overcoming key translational barriers, including real-time access to clinical data, data security, physician approval of "black box" generated results, and performance evaluation will allow for a fundamental shift in medical practice, where specialized tools will aid the healthcare team in providing better patient care.
尽管机器学习(ML)在金融和营销等领域的应用不断扩大,但在临床医学的日常实践中,其应用几乎不存在。在这项系统评价中,我们描述了临床医学中应用 ML 改善患者护理的各个领域。
按照 PRISMA 指南,使用 Medline(R)、EBM Reviews、Embase、Psych Info 和 Cochrane 数据库进行了系统评价,重点关注直接解决临床问题的使用 ML 的人类研究。纳入的研究发表于 2000 年 1 月 1 日至 2018 年 5 月 1 日,提供了所使用的 ML 工具的性能指标。
共审查了 1909 篇独特的出版物,其中 378 篇回顾性文章和 8 篇前瞻性文章符合纳入标准。回顾性出版物的频率不断增加,其中 61%的文章在过去 4 年内发表。符合我们纳入标准的前瞻性文章仅占 2%。这些研究采用前瞻性队列设计,平均样本量为 531 例。
描述临床医学中使用 ML 的文献大多是回顾性的,通常概述了对改善患者护理产生影响的概念验证方法。我们推测,识别和克服关键的转化障碍,包括实时访问临床数据、数据安全、医生对“黑箱”生成结果的认可以及性能评估,将允许医疗实践发生根本性转变,其中专门的工具将帮助医疗团队提供更好的患者护理。